Enhanced in vitro activity of WR99210 in combination with dapsone against Mycobacterium avium complex.
WR99210, a dihydrofolate reductase inhibitor, has promising in vitro activity against Mycobacterium avium complex (MAC). The in vitro activities of WR99210 alone and in combination with a fixed concentration of dapsone (0.5 microgram/ml) were evaluated against 35 clinical MAC isolates by a broth dil...
Salvato in:
| Pubblicato in: | Antimicrob Agents Chemother |
|---|---|
| Autori principali: | , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
American Society for Microbiology (ASM)
1996
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC163591/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/8913480/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.40.11.2644 |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|
